Literature DB >> 2938399

Experimental clioquinol intoxication in rats: abnormalities in optic nerves and small nerve cells of dorsal root ganglia.

K Ozawa, K Saida, T Saida.   

Abstract

Pathological abnormalities in the central (CNS) and peripheral nervous system (PNS) were produced in rats by daily administration of 300-400 mg/kg clioquinol for 7-40 days. The changes comprised axonal degeneration of optic nerve fibers and mitochondrial swellings in small nerve cells of dorsal root ganglia. There were occasional myelin splittings in the spinal nerve roots. No apparent changes were observed in the spinal cord or peripheral nerves. Similar changes were occasionally encountered to a lesser extent in control rats by restricting the diet and water to maintain the body weight comparable to the ranges of experimental animals. It seemed that not only clioquinol intoxication but nutritional deficiency also contributed, in part, to the production of these CNS and PNS abnormalities. The possibility of the presence of peripheral neuropathy in subacute myelooptic neuropathy is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938399     DOI: 10.1007/bf00688304

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  30 in total

1.  Peripheral neuropathy in ageing rats fed clioquinol and a maize diet.

Authors:  E L Jones; C E Searle; W T Smith
Journal:  Acta Neuropathol       Date:  1973-05-16       Impact factor: 17.088

2.  Sural nerve conduction velocity in peripheral neuropathies and subacute myelo-optico-neuropathies (SMON).

Authors:  Y Murai; Y Kuroiwa
Journal:  J Neurol Sci       Date:  1973-11       Impact factor: 3.181

3.  The effects of methyl-mercury-dicyandiamide on the peripheral nerves and spinal cord of rats.

Authors:  J B Cavanagh; F C Chen
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

4.  Identification of green pigment and analysis of clioquinol in specimens from patients with subacute myelo-optico-neuropathy.

Authors:  Z Tamura; M Yoshioka; T Imanari; J Fukaya; J Kusaka
Journal:  Clin Chim Acta       Date:  1973-08-17       Impact factor: 3.786

5.  Pathogenesis of the optic nerve lesion in vitamin A-deficient calves.

Authors:  K C Hayes; S W Nielsen; H D Eaton
Journal:  Arch Ophthalmol       Date:  1968-12

6.  Myeloneuropathy with abdominal disorders in Japan. A clinical study of 752 cases.

Authors:  I Sobue; K Ando; M Iida; T Takayanagi; Y Yamamura; Y Matsuoka
Journal:  Neurology       Date:  1971-02       Impact factor: 9.910

7.  Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan.

Authors:  G Baumgartner; M J Gawel; H E Kaeser; C A Pallis; F C Rose; H H Schaumburg; P K Thomas; N H Wadia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-12       Impact factor: 10.154

8.  The evolution of cellular degeneration in dorsal root ganglia exposed to doxorubicin in tissue culture.

Authors:  J C Zagoren; M Seelig; M B Bornstein; P S Spencer
Journal:  J Neuropathol Exp Neurol       Date:  1984-07       Impact factor: 3.685

9.  Clioquinol toxicity in the dog.

Authors:  A N Worden; R Heywood; D E Prentice; H Chesterman; K Skerrett; P E Thomann
Journal:  Toxicology       Date:  1978-03       Impact factor: 4.221

10.  The neuropathology of subacute myelo-optico-neuropathy, "SMON", in the humans: --with special reference to the quinoform intoxication.

Authors:  H Shiraki
Journal:  Jpn J Med Sci Biol       Date:  1975
View more
  2 in total

1.  Optic neuropathy in a herd of beef cattle in Alberta associated with consumption of moldy corn.

Authors:  Lynne S Sandmeyer; Vladimir Vujanovic; Lyall Petrie; John R Campbell; Bianca S Bauer; Andrew L Allen; Bruce H Grahn
Journal:  Can Vet J       Date:  2015-03       Impact factor: 1.008

2.  Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+.

Authors:  David A Andersson; Clive Gentry; Sian Moss; Stuart Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-05       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.